메뉴 건너뛰기




Volumn 57, Issue 2, 2011, Pages

Metabolic actions could confound advantageous effects of combined angiotensin II receptor and neprilysin inhibition

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; MEMBRANE METALLOENDOPEPTIDASE; NATRIURETIC PEPTIDE RECEPTOR A;

EID: 79551471674     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.165159     Document Type: Letter
Times cited : (28)

References (5)
  • 1
    • 77950628157 scopus 로고    scopus 로고
    • Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: A randomised, double-blind, placebo-controlled, active comparator study
    • Ruilope LM, Dukat A, Bohm M, Lacourciere Y, Gong J, Lefkowitz MP. Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study. Lancet. 2010;375:1255-1266.
    • (2010) Lancet , vol.375 , pp. 1255-1266
    • Ruilope, L.M.1    Dukat, A.2    Bohm, M.3    Lacourciere, Y.4    Gong, J.5    Lefkowitz, M.P.6
  • 5
    • 33845565186 scopus 로고    scopus 로고
    • Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure
    • von Haehling S, Doehner W, Anker SD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res. 2007;73:298-309.
    • (2007) Cardiovasc Res , vol.73 , pp. 298-309
    • Von Haehling, S.1    Doehner, W.2    Anker, S.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.